Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04996004
Title A Trial of TTI-621 in Combination With Doxorubicin in Patients With Leiomyosarcoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Trillium Therapeutics Inc.

dedifferentiated liposarcoma




epithelioid sarcoma


Doxorubicin + TTI-621

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Cancer Center of Southern California Recruiting Santa Monica California 90403 United States Details
Cancer Center Referral Office Not yet recruiting Jacksonville Florida 32224 United States Details
Moffitt Cancer Center Recruiting Tampa Florida 33612 United States Details
University of Iowa Hospitals and Clinics Recruiting Iowa City Iowa 52242 United States Details
University of Michigan Rogel Cancer Center Recruiting Ann Arbor Michigan 48109 United States Details
Memorial Sloan Kettering Cancer Center - Main Campus Recruiting New York New York 10065 United States Details
Duke Sarcoma Research Not yet recruiting Durham North Carolina 27710 United States Details
University Hospitals Seidman Cancer Center Recruiting Cleveland Ohio 44106 United States Details
Oregon Health & Science University Recruiting Portland Oregon 97239 United States Details
Virginia Cancer Specialists Recruiting Fairfax Virginia 22031 United States Details
University of Wisconsin Recruiting Madison Wisconsin 53715 United States Details
*Shaded cells indicate that there was no data available from for the field